Venture Life Share Discussion Threads

[eagle eye] 06/6/2023 19:34

Now on the train following a full afternoon with VLG. Tamsin of PI World did recording which will exceed 3 hours. The presentation document will weigh in at over 100 pages and will be available soon.
Attendance was between 50 and 60 people, though that included a fair number of staff.
The full team from Biokosmes manufacturing facility in Italy attended and were generous with their time and knowledge.
Key point is there is no acquisition in the pipeline for this FY. Concentration is on organic growth and cash generation.
Thanks to everyone who put the time and effort in organising the event.
Eagle Eye

[celeritas] 05/6/2023 13:51

Had a top up earlier, this is a long term hold with the current share price a total anomaly.

[eagle eye] 05/6/2023 11:06

Just a reminder....this event is tomorrow.
See you there!

CAPITAL MARKETS EVENT

Date: TUESDAY 6th JUNE in LONDON, 2 - 5pm.

Venture Life Group plc (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, announces that it will host a capital markets event for analysts and investors on 6 June 2023.

The event will be held at the offices of Simmons & Simmons LLP, 1 Ropemaker Street, London EC26 9SS, and senior executives and operational management will be presenting on the following:

-- The Venture Life key brands, being Balance Activ, Lift and Earol;
-- UK and international distribution, and how products are sold via each channel;
-- The Company's development and manufacturing capabilities;
-- Managing supply chains in the current environment; and
-- The Customer Brands that the Company manufactures.
The event will start at 14:00 GMT and is expected to finish at 17:00 GMT.

If you wish to attend the event in person, please RSVP to [e-mail] or [e-mail]

The Company invites retail investors to attend in person; however, there will be a limit to the number that can attend, and places will be given on a first come first serve basis.

[celeritas] 26/5/2023 14:16

They also had a further £20m open to them on the same terms. It might be worth taking advantage as interest rates were much lower when the RCF was taken out. The RCF was essentially for cash generating acquisitions.

[eagle eye] 26/5/2023 11:06

Good point and hopefully that is the case.

[celeritas] 26/5/2023 10:06

Surely any takeover would be covered by the £30m RCF.

[eagle eye] 26/5/2023 09:22

I may be wrong, but with recent share price weakness and Capital Markets Event coming up, maybe the City has wind of an acquisition and cash raise coming up.
It's pure speculation but these things do happen.

[celeritas] 25/5/2023 14:59

Business is motoring along nicely, the current share price is an anomaly so no wonder a director took a nice chunk, he does like a £50k block.
I expect we'll see a few more.
I've no doubt Paul McGreevy is increasing Vlg's international footprint.

[qs99] 25/5/2023 14:07

Meaningful director purchase IMO/DYOR

[celeritas] 25/5/2023 11:31

A little top up for me, getting a nice avg now.
You have to take advantage when the mkt is irrational.

[qs99] 22/5/2023 11:29

Chugging along nicely,....

[celeritas] 22/5/2023 11:00

Great to see, debt will be under 1x come end of year, probs close to 0.8x, fantastic going after HL takeover.. I wonder if any other bolt ons are in their sights.

[brummy_git] 22/5/2023 09:25

Another encouraging trading update from niche OTC healthcare firm Venture life today.

All the details here.

[qs99] 22/5/2023 07:32

Yup, nice update DYOR

[rivaldo] 22/5/2023 07:19

An encouraging AGM statement today. Everything proceeding smoothly with no surprises - which is what we want to see after past hiccups.

VLG are confident about delivering in line with expectations. With the consensus of Cenkos's and Singer's forecasts being 4.92p EPS this year, that puts VLG on a current year P/E of just 8.2.

[eagle eye] 15/5/2023 15:43

A date for the diary:

CAPITAL MARKETS EVENT

Date: TUESDAY 6th JUNE in LONDON, 2 - 5pm.

Venture Life Group plc (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, announces that it will host a capital markets event for analysts and investors on 6 June 2023.

The event will be held at the offices of Simmons & Simmons LLP, 1 Ropemaker Street, London EC26 9SS, and senior executives and operational management will be presenting on the following:

-- The Venture Life key brands, being Balance Activ, Lift and Earol;
-- UK and international distribution, and how products are sold via each channel;
-- The Company's development and manufacturing capabilities;
-- Managing supply chains in the current environment; and
-- The Customer Brands that the Company manufactures.
The event will start at 14:00 GMT and is expected to finish at 17:00 GMT.

If you wish to attend the event in person, please RSVP to [e-mail] or [e-mail] .

The Company invites retail investors to attend in person; however, there will be a limit to the number that can attend, and places will be given on a first come first serve basis.

[mfhmfh] 17/4/2023 14:51

cup & handle on the chart?

[rivaldo] 17/4/2023 08:24

Clive, read prior posts 1592 to 1594 (as well as Simon Thompson's article from the IC posted subsequently) - the P/E is very low with the details shown clearly.

And never believe ADVFN's figures! They are almost always wrong and will anyway usually only quote the misleading headline figures rather than the "true" adjusted figures for the core, continuing business.

[clive7878] 16/4/2023 15:46

Apr 06
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind
Full year 2022 results:
EPS: UK£0.004 (down from UK£0.019 in FY 2021).
Revenue: UK£44.0m (up 34% from FY 2021).
Net income: UK£520.0k (down 78% from FY 2021).
Profit margin: 1.2% (down from 7.3% in FY 2021).
Revenue exceeded analyst estimates by 3.1%. Earnings per share (EPS) missed analyst estimates by 58%.

IC did give the pros of VLG - and it was a glowing article - , but I do wonder what the downside elements are,
such as what is the expected pe ratio for next year?
We do need a full picture however to draw conclusions as to what are the fundamentals.

advfn.com quotes page does say that the eps is 1.91p and the pe ration is 22.2.

[celeritas] 14/4/2023 14:06

The RCF is due for renewal next year, they're already getting on with it. HSBC have took over from SVB so it's business as usual. It was also great to know Santander would take up any slack.

[brad_k] 14/4/2023 13:02

Seems to be a real slog to get back anywhere near the 47-48p we were at in early March. The sap does not seem to have recovered from the SVB RNS. Was there any update on the RCF negotiations in any of their recent presentations?

[celeritas] 14/4/2023 09:37

It doesn't really matter when it went out. All the article is doing is bringing vlg to investors attention.
Very few have noticed vlg, its a bit of an anomaly.

[sharw] 14/4/2023 09:28

The ST article actually went out on the 4th - see



so only the print subscribers/buyers will see it as new today